EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study

Manideepa Maji, Nita Radhakrishnan, Shruti Verma, Aishvarya Diptivilasa, Saikat Mandal

Frontiers in Oncology · 29.07.2026 · 16

DOI: 10.3389/fonc.2026.1876009 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Frontiers in Oncology, online erschienen am 29.07.2026. Verfasst von Manideepa Maji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Institute of Child Health, Noida, India. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Febrile neutropenia (FN) remains a major cause of morbidity and mortality in paediatric haemato-oncology, but routinely available determinants of adverse in-hospital outcome remain incompletely characterised. We aimed to identify baseline clinical, haematological, biochemical, and microbiological factors associated with in-hospital mortality and prolonged fever.

Methods

We conducted a prospective single-centre cohort study of 90 consecutive FN admissions in paediatric haemato-oncology patients. Thirty-nine prespecified baseline predictors were evaluated using Firth penalised-likelihood logistic regression. Multivariable models were prespecified on clinical grounds, and discrimination was internally validated using 500 bootstrap replicates with optimism correction. Prolonged fever was defined as time to defervescence >5 days, with death before defervescence counted as an event.

Results

Of 86 mortality-evaluable episodes, 16 children died in hospital (18.6%). In the multivariable mortality model, any respiratory support (adjusted odds ratio [aOR], 11.9; 95% CI, 2.5–56.9) and lower admission albumin (aOR, 0.29 per 1 g/dL increase; 95% CI, 0.11–0.77) showed the strongest associations with death. Active disease (aOR 3.5, 95% CI 0.87–14.2) and gram-negative bacteraemia (aOR 4.2, 95% CI 0.93–18.9) showed directionally adverse but imprecise associations. The bootstrap-corrected AUC was 0.88. Of 60 classifiable episodes for the secondary outcome, 31 (51.7%) had prolonged fever. Prolonged fever was associated with older age (aOR 1.24 per year, 95% CI 1.05–1.48), lower albumin (aOR 0.31 per 1 g/dL increase, 95% CI 0.12–0.82), any respiratory support (aOR 10.0, 95% CI 0.98–102.0), and gram-negative bacteraemia (aOR 5.5, 95% CI 1.01–30.3). The bootstrap-corrected AUC was 0.85. Neutropenia depth and platelet count were not independently associated with either outcome.

Conclusion

In paediatric haemato-oncology patients with FN, adverse in-hospital outcomes were associated mainly with early or evolving respiratory compromise, lower admission albumin, active disease, and gram-negative bacteraemia. Three of these factors, together with age, were associated with prolonged fever or death before defervescence among classifiable episodes. Albumin should be interpreted as a dynamic marker of acute inflammatory burden, capillary leak, and host reserve rather than as a standalone nutritional measure. These routinely available variables may support exploratory bedside risk appraisal, but external validation is required before clinical implementation.

Schlagwörter

Stichwörter der Autor:innen

blood cancerchildhood cancerfebrile neutropenia (FN)neutropenic feverpaediatric cancerpaediatric cancer care

Autor:innen und Institutionen

  • Postgraduate Institute of Child Health, Noida, India.
  • Hull York Medical School, University of Hull, Hull, United Kingdom.
  • Department of Haematology, Hull University Teaching Hospitals NHS Trust, Hull, United Kingdom.
  • Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
  • NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.

Zitieren

APA

Maji, M., Radhakrishnan, N., Verma, S., Diptivilasa, A., & Mandal, S. (2026). Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1876009

Vancouver

Maji M, Radhakrishnan N, Verma S, Diptivilasa A, Mandal S. Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1876009

BibTeX
@article{Maji2026,
  author = {Maji, Manideepa and Radhakrishnan, Nita and Verma, Shruti and Diptivilasa, Aishvarya and Mandal, Saikat},
  title = {Early clinical determinants of adverse outcomes in paediatric febrile neutropenia: a prospective cohort study},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1876009}
}
Kostenlos starten →